Over the past five years, Ontario has seen a steady increase in the number of people using pre-exposure prophylaxis (PrEP). Between January and March 2020, 8,413 people were on PrEP – up from 289 in 2015. While most of these people live larger cities like Toronto and Ottawa, PrEP use has also increased in regions across the province.
Testing is an essential part of the HIV cascade of care. People living with HIV can only be linked to treatment, care and support services if they have been diagnosed. Once a person is diagnosed, effective treatment will enable them to live a long and healthy life, to have HIV-negative children, and not have to worry about passing on HIV to their sex partners. People who test negative and are at ongoing risk for HIV can be linked to prevention, harm reduction and other services as necessary.
Does your organization support the meaningful engagement of individuals with lived experience of substance use? The assumption and our immediate response to this question should be a resounding yes! However, we know that this is often not the case.
Many creative solutions have been implemented to keep people who use drugs safe, and these solutions need to be scaled up and continued beyond the pandemic, to reach people who don’t live in areas with adequate harm reduction services.
Hepatitis C is curable. Today’s treatment regimens are highly effective and easy to complete. And it has the added benefit of preventing transmission to others, making it possible to eliminate hepatitis C from Canada. However, for many of the most marginalized people affected by hepatitis C in Canada, including people who use drugs, treatment remains frustratingly out of reach. Those who are most at risk are also the ones most often missed by healthcare services.
Editor’s note, January 2022: Some of the approaches and technologies highlighted here are still only available in some regions of Canada. Additionally, HIV self-testing/home-based testing has now been approved for use in Canada. Canada has signed on to global targets to eliminate HIV and hepatitis C as public health threats by 2030. While ambitious, these targets are now a realistic possibility thanks to the effectiveness of modern medications. HIV treatment can suppress the virus so successfully that HIV-positive Canadians who start treatment early can have life expectancies similar to their HIV-negative peers. This also prevents the transmission of HIV to...
